This inventor holds 2 USPTO granted patents. Top assignees: Daiichi Fine Chemical Co., Ltd., Fuji Yakuhin Kogyo Kabushiki Kaisha. Active years: 2001-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2010
Title: Atsunori Aramata: Innovator in Prostaglandin Derivatives
Introduction
Atsunori Aramata is a notable inventor based in Takaoka, Japan. He has made significant contributions to the field of chemistry, particularly in the preparation of prostaglandin derivatives. With a total of two patents to his name, his work has implications in various medical applications.
Latest Patents
Aramata's latest patents include a method for preparing a prostaglandin derivative. This method is represented by a general formula where Ph denotes a phenyl group, and R represents a Calkyl group, a Calkenyl group, a phenyl group, or a benzyl group. The process involves several steps aimed at efficiently, inexpensively, and safely preparing prostaglandin derivatives, with latanoprost being a typical example. Another patent focuses on a process for the preparation of prostaglandins, where a hydroxy-1-alkyne is reacted with a tin hydride compound. The resulting (E,Z)-hydroxyvinylstannanes are separated to yield the (E)-substance, which is further converted into a vinylcopper complex.
Career Highlights
Throughout his career, Atsunori Aramata has worked with prominent companies such as Fuji Yakuhin Kogyo Co., Ltd. and Daiichi Fine Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in the field of chemical innovations.
Collaborations
Aramata has collaborated with notable coworkers, including Noriaki Murata and Tadashi Takeuchi. Their joint efforts have likely enhanced the quality and impact of their research and innovations.
Conclusion
Atsunori Aramata's contributions to the field of prostaglandin derivatives highlight his innovative spirit and dedication to advancing chemical processes. His patents reflect a commitment to improving methods in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile